OREANDA-NEWS. On 26 January 2009 JSC Grindeks informed that the Business plan of the Company anticipates 185 million Lats turnover for 2013. Published information on BNS  (22.01.2009.) – increase of the turnover reaching 300 million Lats in 7-8 year period will be possible only if current growth dynamics will sustain in existing and new markets.

Also we are inform, that JSC Grindeks continues the registration process of original brand product Mildronate® in China, but exact terms of registration completion is prematurely to announce.